News archive

Munich: iPS center CARE starts in 2017

Wednesday, 02 September 2015 13:54

In the following two years, the stem cell technology center "Center for Regenerative Engineering" (CARE) will be built in Munich. According to media reports, the Bavarian Economics Minister Ilse Aigner has pledged 15 million euros start-up funding to the stem cell researcher Prof. Hans Schöler to build up the Translation Centre. 

Last year, the European Chemical Industry Council (Cefic) has launched a research initiative with the goal to initiate a new research collaboration to practically implement the in vitro eye irritation tests. Since safety assessments of chemicals will be based merely on in vitro data over the coming years, there is an urgent need to develop reliable in vitro testing strategies.

An Israeli-German research team headed by Prof. Yaakov Nahmias from the Alexander Grass Center of Bioengineering at the Hebrew University in Jerusalem has developed an organ-on-a-chip model with a tiny human liver, which can be used longer than a month. Since they inserted additionally optoelectronic sensors into the cells, they were able to discover an important toxicity of acetaminophen.

The Hessian state government wants to contribute to the reduction of animal experiments with two new professorships and a reoccupation of a further professorship. At two locations - Frankfurt and Giessen - this project is supported with 2 million euros in the next five years.

DFG promotes lab-on-a-chip research group

Wednesday, 01 July 2015 11:07

In the next few years the Leipzig research group "Integrated chemical micro laboratories" will be supported with a research funding from the German Research Foundation (DFG).

immune2day is a new method for the detection of vaccines. The research group led by Dr. Günter Roth from Freiburg Centre for Biosystems Analysis has developed a copying machine for biomolecules that can copy DNA. In this manner they want detect potential vaccine candidates against pathogens in the shortest time.

Investigation of Nanoparticles in egg

Thursday, 25 June 2015 09:55

Jena scientists headed by Prof. Dr. Dagmar Fischer want to examine long-term effects which result from the uptake of nanoparticles in the body, e.g. caused by contrast agents. For this purpose they want to use cell cultures and an egg-model.

Scientists of Helmholtz Zentrum München have developed a 3D microtissue-based screening system which, for the first time, enables them to test which chemotherapeutic drugs can resensitize breast cancer cells to radiation.

A researcher team from Helmholtz Center Munich has developed a new in vitro model consisting of brain cells which can be used to study latent HIV infections of brain cells.

Scientists at IfADo - Leibniz Research Centre for Working Environment and Human Factors at the TU-Dortmund in cooperation with partners from all over Europe - have developed a method to genetically compare hepatocyte-like cells with real liver cells.